Cargando…

Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data

BACKGROUND: Radiofrequency radiation in the frequency range 30 kHz–300 GHz was evaluated to be Group 2B, i.e. ‘possibly’ carcinogenic to humans, by the International Agency for Research on Cancer (IARC) at WHO in May 2011. Among the evaluated devices were mobile and cordless phones, since they emit...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlberg, Michael, Hedendahl, Lena, Ahonen, Mikko, Koppel, Tarmo, Hardell, Lennart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937579/
https://www.ncbi.nlm.nih.gov/pubmed/27388603
http://dx.doi.org/10.1186/s12885-016-2429-4
_version_ 1782441732662624256
author Carlberg, Michael
Hedendahl, Lena
Ahonen, Mikko
Koppel, Tarmo
Hardell, Lennart
author_facet Carlberg, Michael
Hedendahl, Lena
Ahonen, Mikko
Koppel, Tarmo
Hardell, Lennart
author_sort Carlberg, Michael
collection PubMed
description BACKGROUND: Radiofrequency radiation in the frequency range 30 kHz–300 GHz was evaluated to be Group 2B, i.e. ‘possibly’ carcinogenic to humans, by the International Agency for Research on Cancer (IARC) at WHO in May 2011. Among the evaluated devices were mobile and cordless phones, since they emit radiofrequency electromagnetic fields (RF-EMF). In addition to the brain, another organ, the thyroid gland, also receives high exposure. The incidence of thyroid cancer is increasing in many countries, especially the papillary type that is the most radiosensitive type. METHODS: We used the Swedish Cancer Register to study the incidence of thyroid cancer during 1970–2013 using joinpoint regression analysis. RESULTS: In women, the incidence increased statistically significantly during the whole study period; average annual percentage change (AAPC) +1.19 % (95 % confidence interval (CI) +0.56, +1.83 %). Two joinpoints were detected, 1979 and 2001, with a high increase of the incidence during the last period 2001–2013 with an annual percentage change (APC) of +5.34 % (95 % CI +3.93, +6.77 %). AAPC for all men during 1970–2013 was +0.77 % (95 % CI −0.03, +1.58 %). One joinpoint was detected in 2005 with a statistically significant increase in incidence during 2005–2013; APC +7.56 % (95 % CI +3.34, +11.96 %). Based on NORDCAN data, there was a statistically significant increase in the incidence of thyroid cancer in the Nordic countries during the same time period. In both women and men a joinpoint was detected in 2006. The incidence increased during 2006–2013 in women; APC +6.16 % (95 % CI +3.94, +8.42 %) and in men; APC +6.84 % (95 % CI +3.69, +10.08 %), thus showing similar results as the Swedish Cancer Register. Analyses based on data from the Cancer Register showed that the increasing trend in Sweden was mainly caused by thyroid cancer of the papillary type. CONCLUSIONS: We postulate that the whole increase cannot be attributed to better diagnostic procedures. Increasing exposure to ionizing radiation, e.g. medical computed tomography (CT) scans, and to RF-EMF (non-ionizing radiation) should be further studied. The design of our study does not permit conclusions regarding causality.
format Online
Article
Text
id pubmed-4937579
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49375792016-07-09 Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data Carlberg, Michael Hedendahl, Lena Ahonen, Mikko Koppel, Tarmo Hardell, Lennart BMC Cancer Research Article BACKGROUND: Radiofrequency radiation in the frequency range 30 kHz–300 GHz was evaluated to be Group 2B, i.e. ‘possibly’ carcinogenic to humans, by the International Agency for Research on Cancer (IARC) at WHO in May 2011. Among the evaluated devices were mobile and cordless phones, since they emit radiofrequency electromagnetic fields (RF-EMF). In addition to the brain, another organ, the thyroid gland, also receives high exposure. The incidence of thyroid cancer is increasing in many countries, especially the papillary type that is the most radiosensitive type. METHODS: We used the Swedish Cancer Register to study the incidence of thyroid cancer during 1970–2013 using joinpoint regression analysis. RESULTS: In women, the incidence increased statistically significantly during the whole study period; average annual percentage change (AAPC) +1.19 % (95 % confidence interval (CI) +0.56, +1.83 %). Two joinpoints were detected, 1979 and 2001, with a high increase of the incidence during the last period 2001–2013 with an annual percentage change (APC) of +5.34 % (95 % CI +3.93, +6.77 %). AAPC for all men during 1970–2013 was +0.77 % (95 % CI −0.03, +1.58 %). One joinpoint was detected in 2005 with a statistically significant increase in incidence during 2005–2013; APC +7.56 % (95 % CI +3.34, +11.96 %). Based on NORDCAN data, there was a statistically significant increase in the incidence of thyroid cancer in the Nordic countries during the same time period. In both women and men a joinpoint was detected in 2006. The incidence increased during 2006–2013 in women; APC +6.16 % (95 % CI +3.94, +8.42 %) and in men; APC +6.84 % (95 % CI +3.69, +10.08 %), thus showing similar results as the Swedish Cancer Register. Analyses based on data from the Cancer Register showed that the increasing trend in Sweden was mainly caused by thyroid cancer of the papillary type. CONCLUSIONS: We postulate that the whole increase cannot be attributed to better diagnostic procedures. Increasing exposure to ionizing radiation, e.g. medical computed tomography (CT) scans, and to RF-EMF (non-ionizing radiation) should be further studied. The design of our study does not permit conclusions regarding causality. BioMed Central 2016-07-07 /pmc/articles/PMC4937579/ /pubmed/27388603 http://dx.doi.org/10.1186/s12885-016-2429-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Carlberg, Michael
Hedendahl, Lena
Ahonen, Mikko
Koppel, Tarmo
Hardell, Lennart
Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
title Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
title_full Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
title_fullStr Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
title_full_unstemmed Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
title_short Increasing incidence of thyroid cancer in the Nordic countries with main focus on Swedish data
title_sort increasing incidence of thyroid cancer in the nordic countries with main focus on swedish data
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937579/
https://www.ncbi.nlm.nih.gov/pubmed/27388603
http://dx.doi.org/10.1186/s12885-016-2429-4
work_keys_str_mv AT carlbergmichael increasingincidenceofthyroidcancerinthenordiccountrieswithmainfocusonswedishdata
AT hedendahllena increasingincidenceofthyroidcancerinthenordiccountrieswithmainfocusonswedishdata
AT ahonenmikko increasingincidenceofthyroidcancerinthenordiccountrieswithmainfocusonswedishdata
AT koppeltarmo increasingincidenceofthyroidcancerinthenordiccountrieswithmainfocusonswedishdata
AT hardelllennart increasingincidenceofthyroidcancerinthenordiccountrieswithmainfocusonswedishdata